Frazier Life Sciences Management, L.P.
Position in NAMS — NewAmsterdam Pharma Co N.V.
CIK 1892134
PALO ALTO, CA
Position in NAMS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$623,725,004
+$71,328,126 QoQ
Shares Held
18,589,235
+6.6% QoQ
Ownership
15.6%
of shares outstanding
% of Portfolio
13.58%
of 13F equity value
Holder Rank
#1
of 198 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Frazier Life Sciences Management, L.P. holds $4,497,017,185 across 37 Biotechnology names. NAMS ranks #2 (13.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MIRM |
Mirum Pharmaceuticals, Inc.
|
7,679,684 | $899,060,605 | |
| 2 | NAMS |
NewAmsterdam Pharma Co N.V.
This page
|
18,589,235 | $623,725,004 | |
| 3 | ERAS |
Erasca, Inc.
|
24,975,188 | $457,545,444 | |
| 4 | MBX |
MBX Biosciences, Inc.
|
6,652,013 | $367,191,117 | |
| 5 | ARQT |
Arcutis Biotherapeutics, Inc.
|
9,874,511 | $258,909,678 | |
| 6 | TRVI |
Trevi Therapeutics, Inc.
|
9,939,447 | $185,370,686 | |
| 7 | KRYS |
Krystal Biotech, Inc.
|
481,307 | $178,887,372 | |
| 8 | MAZE |
Maze Therapeutics, Inc.
|
5,032,915 | $150,182,183 |
All Filings in NAMS
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 NAMSW | $10,692,116 | 500,333 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $613,032,888 | 18,088,902 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 NAMSW | $10,026,673 | 500,333 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $542,370,205 | 16,943,774 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 NAMSW | $11,507,659 | 500,333 | Shares | Sole | 2026-02-13 | |
| 2025-12-31 | $594,387,591 | 16,943,774 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 NAMSW | $8,560,697 | 500,333 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $475,003,628 | 16,701,956 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 NAMSW | $4,002,664 | 500,333 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $300,754,110 | 16,607,074 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 NAMSW | $4,497,993 | 500,333 | Shares | Sole | 2025-05-15 | |
| 2025-03-31 | $329,903,076 | 16,116,418 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 NAMSW | $7,129,745 | 500,333 | Shares | Sole | 2025-02-18 | |
| 2024-12-31 | $409,051,942 | 15,916,418 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 NAMSW | $3,502,331 | 500,333 | Shares | Sole | 2024-11-15 | |
| 2024-09-30 | $213,396,220 | 12,855,194 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 NAMSW | $4,362,903 | 500,333 | Shares | Sole | 2024-08-15 | |
| 2024-06-30 | $234,879,575 | 12,226,943 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 NAMSW | $5,523,676 | 500,333 | Shares | Sole | 2024-05-15 | |
| 2024-03-31 | $289,167,201 | 12,226,943 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 NAMSW | $1,566,042 | 500,333 | Shares | Sole | 2024-02-14 | |
| 2023-12-31 | $135,511,144 | 12,131,705 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 NAMSW | $950,632 | 500,333 | Shares | Sole | 2023-11-14 | |
| 2023-09-30 | $112,218,271 | 12,131,705 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 NAMSW | $1,045,695 | 500,333 | Shares | Sole | 2023-08-14 | |
| 2023-06-30 | $129,265,737 | 10,871,803 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 NAMSW | $920,612 | 500,333 | Shares | Sole | 2023-05-15 | |
| 2023-03-31 | $123,868,966 | 9,341,551 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 NAMSW | $434,289 | 500,333 | Shares | Sole | 2023-02-07 | |
| 2022-12-31 | $101,822,905 | 9,341,551 | Shares | Sole | 2023-02-07 | |
| No filing history on record for this holder in this stock. | ||||||